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Introduction
Many oxadiazole-containing compounds have been developed as drug candidates since the 1970's (Allen et al., 1971; Saunders et al., 1990; Allan et al., 2006; Bateman et al., 2006; Hall et al., 2007) . These compounds have been used for various indications including post-surgical dermal scarring, asthma, pain, Alzheimer's disease, and anticonvulsants. Incorporation of an oxadiazole ring may be used in place of an ester moiety to offer enhanced resistance to hydrolytic cleavage mediated by esterases (Dalvie et al., 2002) . Though many oxadiazolecontaining drug candidates have been reported, information regarding the biotransformation of the oxadiazole ring is scarce. In fact, the only oxadiazole isomer with reported biotransformation is the 1,2,4-oxadiazole, which can undergo a ring opening through reductive cleavage of the N-O bond (Lan et al., 1973; Dalvie et al., 2002; Bateman et al., 2006; Allan et al., 2006) . Setileuton The 5-lipoxygenase enzyme catalyzes the initial steps in the conversion of arachidonic acid to leukotrienes (Radmark and Samuelsson, 2005; Funk, 2005) . Leukotrienes are potentially important mediators of inflammation and have been implicated in the pathology of several diseases including asthma, psoriasis, rheumatoid arthritis, and atherosclerosis (Ford-Hutchinson, 1985; Israel et al., 1990; Huang L et al., 2004; Funk, 2005) . It is thought that inhibition of the 5-LO enzyme could be a means of treating such diseases. Setileuton, a selective inhibitor of 5-LO, is under investigation for the treatment of asthma and atherosclerosis.
During the development of setileuton, a 1,3,4-oxadiazole ring opened metabolite (M5) was identified in rat, dog, and human liver microsome and hepatocyte incubations. In a rat This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on February 16, 2011 as DOI: 10.1124 at ASPET Journals on June 24, 2017 dmd.aspetjournals.org Downloaded from DMD # 37366 5 disposition study, M5 was identified in the urine, bile, and plasma. The mechanism of the metabolic ring opening, which was examined in rat liver microsomes and recombinantly expressed enzymes, was shown to be cytochrome P450 (P450) mediated. The evidence supporting this conclusion is described in this report and three potential mechanisms for this twostep biotransformation are proposed. An alternative, comparatively slow, pathway of chemical hydrolysis also was identified.
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Materials and Methods
Chemicals. Acetonitrile, premixed 0.1% aqueous formic acid, NADPH, 1M potassium phosphate buffer, and water-18 O (95 atom % excess, Isotec) were purchased from Sigma-Aldrich (St. Louis, MO). Argon was obtained from Airgas (Radnor, PA). Oxygen-18 gas (97.8 atom % excess) was purchased from Cambridge Isotope Laboratories (Andover, MA). Meperidine hydrochloride was obtained from Spectrum Chemical and Laboratory Products (Gardena, CA).
All other reagents were of analytical grade or higher.
Setileuton ( Figure 1 ) was synthesized at Merck Research Laboratories (Merck Frosst, Canada) as described previously (Ducharme et al., 2010) . Synthetic M5 (Figure 2 ) also was synthesized at Merck Research Laboratories (Merck Frosst, Canada). Analytical amounts of M5
were prepared in a three step synthesis starting from compound A (supplemental material in Ducharme et al., 2010) . In the presence of sodium hydride and di-tert-butyl iminodicaboxylate compound A was converted to B in a 74% isolated yield. A mixture of trifluoroacetic acid and B was stirred for 16 hours at room temperature affording the primary amine C in quantitative yield.
A solution of C and 5-((S)-1-hydroxy-1-trifluoromethyl-propyl)-3H-[1,3,4]oxadiazol-2-one (F) (supplemental information) was stirred at 65 °C over night to provide M5 as a synthetic standard.
Pooled liver microsomes and recombinant P450. Pooled male rat liver microsomes (RLM)
were obtained from XenoTech (Lenexa, KS). Microsomes prepared from baculovirus-infected insect cells expressing rat CYP 1A2, 2A1, 2B1, 2C11, 2C13, 2D1, 2J3, 2J4, 3A1, and 3A2 were obtained in-house from Drug Metabolism, Merck Research Laboratories (West Point, PA; preparation similar to Shou et al., 2003) . Microsomes prepared from baculovirus-infected insect cells expressing rat CYP 1A1, 2A2, 2C6, 2C12, and 2D2 were obtained from BD Gentest (Bedford, MA). The control baculosomes were obtained from Panvera (Madison, WI).
This article has not been copyedited and formatted. The final version may differ from this version. For kinetic studies using RLM, CYP3A1/2 and CYP1A1/2, incubation conditions were identified under which the formation of M5 was linear with respect to time and protein concentration (data not shown). Incubation mixtures contained 0.1 M phosphate buffer, protein (0.75 mg/mL RLM, 100 or 300 pmol/mL recombinant P450), and setileuton (0.2-100 µM).
Samples were pre-incubated for 3 minutes at 37°C before initiating reaction by addition of 1 mM NADPH. Incubations were conducted for 10 minutes and the reactions were terminated and samples processed for mass spectrometric analysis as described above. O, male RLM (1 mg/mL), meperidine (50 µM) a known esterase substrate, and 1 mM NADPH were prepared as a positive control for esterase activity. These samples were incubated for 40 minutes at 37°C in a shaking water bath. At the end of the incubation, two volumes of acetonitrile were added to the mixtures to terminate the reaction.
Incubation in
Samples were centrifuged and the supernatants were transferred into glass culture tubes and evaporated to dryness under a nitrogen stream. The sample residues were reconstituted in 5% acetonitrile in aqueous 0.1% formic acid prior to LC-MS analysis.
This article has not been copyedited and formatted. The final version may differ from this version. Meperidine incubation samples were injected onto a Phenomenex Synergi Polar-RP (250x4.6 mm, 4 µm) column. The mobile phase composition and flow rate were the same as above. The initial condition was 5% B and was held for 5 minutes. The gradient then was increased linearly to 90% B at 15 minutes and held at 90% B for 5 minutes. The column was reequilibrated under the initial conditions for 5 minutes before the next injection.
In all cases, column effluent was split such that ~150-200 µL/minute flowed to the mass spectrometer source and the remainder to waste. All mass spectrometric analyses were carried out with electrospray ionization in the positive mode.
Kinetic analysis. Data from incubations of setileuton with RLM, CYP3A1/2 and CYP1A1/2 for kinetic studies were used to fit equations describing the classic hyperbolic (equation 1) or the sigmoidal (equation 2) kinetic models used previously (Huang W et al., 2004) :
where v is the initial velocity, V max is the maximum velocity, [S] is substrate concentration, K m is the Michaelis constant (substrate concentration at which velocity is 50% V max ), n is the Hill coefficient, and S 50 is the substrate concentration at which velocity is 50% V max . The kinetic parameters were estimated using SigmaPlot (version 9.01, Systat Software, Inc., Point Richmond, CA).
This article has not been copyedited and formatted. The final version may differ from this version. (Figure 2 ) had a molecular ion which was 18 Daltons higher than that of setileuton, and accurate mass analysis supported the conclusion that this was due to the net addition of the elements of water. The product ion spectrum of metabolite M5 (Figure 3) contained the m/z 253 ion, which was detected in the product ion spectrum of setileuton, resulting from the neutral loss of the oxadiazole portion of the molecule. This suggested that the structural modification occurred to the oxadiazole portion of the molecule.
Structural identification was confirmed by matching the retention time and product ion spectrum to the synthetic standard of M5 (to be discussed later). Metabolite M5 subsequently was isolated from rat urine, and the 1 H-NMR spectrum of the isolated M5 was compared to the synthetically prepared compound (Figure 4 ). The two 1D 1 H-NMR spectra in Figure 4 have identical chemical shifts and coupling patterns for all proton signals, which indicates that the two samples have the same chemical structure.
To distinguish between oxidation and either chemical or enzymatic hydrolysis, setileuton was incubated with rat liver microsomes in the presence and absence of NADPH, and the formation of M5 was shown to be NADPH dependent (Table 1 ). This suggested that the formation was oxidative and led to an investigation of the enzymes and mechanism responsible for metabolite formation. formation of M5 at appreciable levels (data not shown). Kinetic studies were conducted in male rat liver microsomes as well as recombinant rat CYP1A1, CYP1A2, CYP3A1, and CYP3A2 to determine the K m and V max ( Figure 5 ). Although the metabolic formation of M5 presumably involves two biotransformation steps, it was assumed that one step was rate limiting and the other step was rapid enough to not impact the kinetics. M5 formation in male rat liver microsomes and in expressed CYP1A2 and CYP3A1 displayed sigmoidal kinetics with This article has not been copyedited and formatted. The final version may differ from this version. Furthermore, a variety of two dimensional 1 H-and 13 C-NMR experiments allowed the unambiguous assignment of all proton and carbon atoms in the synthetic M5 (supplemental information).
Oxygen-18 Label Experiments. When setileuton was incubated with rat liver microsomes
under an atmosphere of oxygen-18 gas, mass spectrometric analysis showed that the molecular to esterase activity (Luttrell and Castle, 1988) . Overall the result from the in vitro study suggested that the oxygen incorporated into M5 did not originate from the water.
When a saturated aqueous solution of setileuton was stressed in a capped test tube at 80°C for 6 days, M5 was formed via hydrolysis. When the aqueous solution was prepared in oxygen-18 labeled water, the oxygen-18 was incorporated into the resulting M5, which was
shown by a net increase of 2 Daltons compared to standard observable by mass spectrometry.
Further analysis of the labeled metabolite by collision induced dissociation suggested that the labeled oxygen was primarily incorporated on carbon 2 of the oxadiazole due to an increase of 2
Daltons of the m/z 296 ion to 298 while the m/z 253 ion remained unchanged ( Figure 6C ). This suggested a second, separate mechanism for hydrolysis.
Discussion
During the development of setileuton, the metabolite M5 was identified which represented the addition of 18 Daltons (net addition of the elements of water) to the oxadiazole portion of the parent molecule. Biotransformations for the 1,2,4-oxadiazole are well-known in the literature (Lan et al., 1973 , Yabuki et al., 1993 Dalvie et al., 2002) , but no examples of biotransformations of 1,3,4-oxadiazoles could be identified. The 1,2,4-oxadiazoles undergo metabolic ring opening through reductive cleavage of the N-O bond (Lan et al., 1973; Dalvie et al., 2002; Bateman et al., 2006; Allan et al., 2006) or an unknown mechanism (Yabuki et al., 1993) . In some instances, there is further hydrolysis of the amide and carboxylic acid resulting from cleavage of the oxadiazole ring (Allan et al., 2006) . This led to an investigation into the mechanism of the novel ring opening of the 1,3,4-oxadiazole to determine if it was oxidative or hydrolytic.
The formation of M5 in male RLM incubations was dependent upon the presence of NADPH which indicated the probable involvement of P450 isoforms. Various recombinant rat P450s were tested, and it was determined that CYP1A1, CYP1A2, CYP3A1, and CYP3A2 were capable of forming the metabolite in significant quantities. Further kinetic studies revealed that metabolite formation in CYP1A2 and CYP3A1 displayed sigmoidal kinetics similar to that observed in male rat liver microsomes. In contrast, catalysis mediated by CYP1A1 and CYP3A2
conformed to Michaelis-Menten kinetics. These results suggested that CYP1A2 and CYP3A1
likely were contributing to M5 formation in male rat liver. Since the expression level of CYP3A1 was reported to be very low in adult male rat liver (Ribeiro and Lechner, 1992; Rich and Boobis, 1997; Rodrigues et al., 2003) , CYP1A2 was likely the major P450 isoform contributing to M5 formation in male rat liver microsomes. There is little information available on gender differences in the expression of CYP1A2 in rat liver. There is some evidence that the This article has not been copyedited and formatted. The final version may differ from this version. protein level of CYP1A2 is slightly higher in female rat liver than male rat liver (Iba et al., 1999; Kato and Yamazoe, 1992) , however, this is not likely to cause a gender difference in the formation of M5.
Additional studies were conducted with stable labeled molecular oxygen and water to investigate the origin of the oxygen incorporated into the metabolite and the mechanism of M5 formation. When incubations were conducted for 30 minutes in the presence of NADPH at 37°C
under an atmosphere of stable labeled molecular oxygen, the oxygen-18 was incorporated in the M5 metabolite formed. In addition, following collision induced dissociation, the m/z 187 ion was completely replaced by m/z 189 while the m/z 296 ion was unchanged ( Figure 6B inset).
The oxygen-18 gas was 97.8% enriched, thus near total replacement was expected. These results indicated that the incorporation of the oxygen occurred on carbon 5 of the oxadiazole. However, when incubations were conducted in buffer prepared in oxygen-18 labeled water in the presence of NADPH, there was no incorporation of the labeled oxygen in the metabolite after 30 minutes at 37°C. This supported our hypothesis that metabolite formation was oxidative rather than chemical or enzyme mediated hydrolysis.
Chemical hydrolysis of 1,3,4-oxadiazoles is known in acidic environments and leads directly to a ring opened product (Suyama et al., 2003; Johnson et al., 2008) . To determine if this could occur for setileuton, a saturated aqueous solution of setileuton was stressed for 6 days at 80°C. Under these conditions it was possible to form M5 through chemical hydrolysis, and when oxygen-18 labeled water was utilized in this experiment, the labeled oxygen was incorporated. However, the chemical hydrolysis process is slow (Table 1 ) and therefore not a significant contributor to the M5 metabolite formed in liver microsome incubations. Even so, M5 was detected as a degradation product in the bulk active pharmaceutical material.
This article has not been copyedited and formatted. The final version may differ from this version. enriched, so this indicated that a small amount of the M5 formed involved nucleophilic attack of carbon 5 of the oxadiazole while nucleophilic attack of carbon 2 was preferred. Carbon 2 of the oxadiazole ring is more electron deficient because of the substitution pattern. In addition, there is increased steric hindrance on carbon 5 due to the bulky 1-hydroxy-1-(trifluoromethyl)propyl group. These factors make nucleophilic attack on carbon 2 more likely and explain the preference for the labeled oxygen incorporation on carbon 2.
In contrast to the single step ring opening of the 1,2,4-oxadizoles, the mechanism for metabolic formation of M5 appears to involve two steps, an oxidation and a reduction, to form the final product. Three possible mechanisms are proposed in this report (Figures 7-9 ). The first proposed mechanism (Figure 7) involves reduction, possibly mediated by P450s, followed by oxidation and rearrangement to form M5. All attempts failed to identify the reduced intermediate (Figure 7) , and while this does not rule out the mechanism it did lead to This article has not been copyedited and formatted. The final version may differ from this version. Figure 9 ) were unsuccessful, which could be due to instability of the intermediate (Fahr and Lind, 1966) . All three mechanisms remain plausible explanations of the two-step process to form M5.
In conclusion, a novel P450 mediated ring opening of a 1,3,4-oxadiazole has been investigated. Metabolite formation displays sigmoidal kinetics in incubations with rat liver microsomes, CYP1A2, and CYP3A1. Expression levels of the enzymes in adult male rat liver indicated that CYP1A2 is most likely responsible for the metabolic formation of M5. Three possible mechanisms for this two step biotransformation have been proposed, though we have been unable to differentiate between them to this point. The metabolite can be formed through chemical hydrolysis, and this was detected in the bulk active pharmaceutical material, but the process is slow under physiologic conditions and probably is not a significant contributor to total metabolite formation. The only oxadiazole isomer with reported metabolism is the 1,2,4-oxadiazole, therefore, this is the first reported metabolism of the 1,3,4-oxadiazole ring.
Di-tert-butyl {[4-(4-fluorophenyl)-2-oxo-2H-chromen-7-yl]methyl}imidodicarbonate (B):
To a stirred solution of di-tert-butyl-iminodicarboxylate (326 mg, 1.50 mmol) in DMF (5 mL) was added sodium hydride 60% in oil (60 mg, 1.50 mmol). The reaction mixture was stirred for 10 minutes at room temperature and a solution of A (455 mg, 1.37 mmol) in DMF (2 mL) was added. After 2 hours the reaction was poured into a saturated aqueous ammonium chloride solution and the aqueous layer was extracted with ethyl acetate (EtOAc). The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered and concentrated under reduced pressure. The crude residue obtained was purified by column chromatography (EtOAc/ toluene, 10:90) to afford B.
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7-(aminomethyl)-4-(4-fluorophenyl)-2H-chromen-2-one (C):
A solution of B (480 mg, 1.02 mmol) and trifluoroacetic acid (1 ml) in CH 2 Cl 2 (5 mL) was stirred at room temperature overnight. The solution then was concentrated and partitioned between EtOAc and saturated aqueous NaHCO 3 . The aqueous layer was extracted with EtOAc, the combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered and concentrated under reduced pressure to provide C.
N-{[4-(4-fluorophenyl)-2-oxo-2H-chromen-7-yl]methyl}-2-[(2S)-2-hydroxy-2-(trifluoromethyl)butanoyl]hydrazinecarboxamide (M5):
A solution of C (47 mg, 0.17 mmol) and F (37 mg, 0.17 mmol) in dioxane (2 mL) was stirred at 65 °C for 16 hours. The solution then was partitioned between EtOAc and saturated aqueous NaHCO 3 . The aqueous layer was extracted with EtOAc, the combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered and concentrated under reduced pressure. The crude residue obtained was purified by column chromatography (Acetone/ CH 2 Cl 2 , 40:60) to provide synthetic M5.
Synthesis of F:
THF, tetrahydrofuran
(2S)-2-hydroxy-2-(trifluoromethyl)butanehydrazide (E):
Synthesis of D was described in Ducharme et al. 2010 . To a solution of (2S) D (2.2 g, 11.7 mmol) was added hydrazine monohydrate (1.1 ml, 23.5 mmol). The mixture was heated at 110 °C for 4 hours and cooled down to room temperature. After evaporation to dryness, the residue was filtered through a pad of silica gel (EtOAc/hexanes) to afford (2S) E.
5-((S)-1-hydroxy-1-trifluoromethyl-propyl)-3H-[1,3,4]oxadiazol-2-one (F):
To a solution of (2S) E (100 mg, 0.54 mmol) in THF (3 mL) at 0 °C was slowly added phosgene 20% solution in toluene (306 μl 0.59 mmol). The solution was stirred 1 hour at room temperature Supplemental information S-3 after which the reaction was poured into a saturated aqueous NaHCO 3 solution. The aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried over Na 2 SO 4 , filtered and concentrated under reduced pressure to afford F.
II. Full NMR characterization of M5.
M5: proton resonances are in plain font, carbon resonances are in bold font 1 H NMR Spectra
